Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Jul;63(7):2612–2618. doi: 10.1128/iai.63.7.2612-2618.1995

Characterization of an antiproliferative surface-associated protein from Actinobacillus actinomycetemcomitans which can be neutralized by sera from a proportion of patients with localized juvenile periodontitis.

P A White 1, M Wilson 1, S P Nair 1, A C Kirby 1, K Reddi 1, B Henderson 1
PMCID: PMC173350  PMID: 7790076

Abstract

The gentle agitation of suspensions of Actinobacillus actinomycetemcomitans serotype a, b, or c in saline resulted in the release of a proteinaceous surface-associated material (SAM) which produced a dose-dependent inhibition of tritiated thymidine incorporation by the osteoblast-like cell line MG63 in culture. This cell line was sensitive to low concentrations of SAM (50% inhibitory concentration, 200 ng/ml for serotype c). Immunoglobulin G antibodies to constituents of the SAM were found in the blood of patients with localized juvenile periodontitis (LJP). Sera from 9 of 16 patients with LJP significantly neutralized the antiproliferative activity of the SAM, while sera from 15 controls, with no evidence of periodontal disease, were unable to neutralize this activity. Neutralization was not directly related to the patient's antibody titer to the whole SAM. Characterization of the antiproliferative activity in the SAM demonstrated that it was not cytotoxic and was heat and trypsin sensitive. The active component separated in a well-defined peak in anion-exchange high-performance liquid chromatography (HPLC) which, when further analyzed by size exclusion HPLC, revealed a single active peak, which had an apparent molecular mass of approximately 8 kDa. The lipopolysaccharide from A. actinomycetemcomitans was only weakly active. SAM from Porphyromonas gingivalis W50 and Eikenella corrodens NCTC 10596 did not exhibit any antiproliferative activity with this cell line, even at concentrations as high as 10 micrograms/ml. This study has shown that SAM from A. actinomycetemcomitans contains a potent antiproliferative protein whose activity can be neutralized by antibodies in the sera from some patients with LJP.

Full Text

The Full Text of this article is available as a PDF (281.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ebersole J. L., Sandoval M. N., Steffen M. J., Cappelli D. Serum antibody in Actinobacillus actinomycetemcomitans-infected patients with periodontal disease. Infect Immun. 1991 May;59(5):1795–1802. doi: 10.1128/iai.59.5.1795-1802.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Helgeland K., Nordby O. Cell cycle-specific growth inhibitory effect on human gingival fibroblasts of a toxin isolated from the culture medium of Actinobacillus actinomycetemcomitans. J Periodontal Res. 1993 May;28(3):161–165. doi: 10.1111/j.1600-0765.1993.tb01064.x. [DOI] [PubMed] [Google Scholar]
  3. Kamen P. R. Inhibition of keratinocyte proliferation by extracts of Actinobacillus actinomycetemcomitans. Infect Immun. 1983 Dec;42(3):1191–1194. doi: 10.1128/iai.42.3.1191-1194.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kamin S., Harvey W., Wilson M., Scutt A. Inhibition of fibroblast proliferation and collagen synthesis by capsular material from Actinobacillus actinomycetemcomitans. J Med Microbiol. 1986 Nov;22(3):245–249. doi: 10.1099/00222615-22-3-245. [DOI] [PubMed] [Google Scholar]
  5. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  6. Meghji S., Henderson B., Kirby A., Newman H. N., Wilson M. Serum antibody response to surface-associated material from periodontopathogenic bacteria. FEMS Immunol Med Microbiol. 1995 Jan;10(2):101–108. doi: 10.1111/j.1574-695X.1995.tb00017.x. [DOI] [PubMed] [Google Scholar]
  7. Meghji S., Henderson B., Wilson M. Higher-titer antisera from patients with periodontal disease inhibit bacterial capsule-induced bone breakdown. J Periodontal Res. 1993 Mar;28(2):115–121. doi: 10.1111/j.1600-0765.1993.tb01058.x. [DOI] [PubMed] [Google Scholar]
  8. Meghji S., Wilson M., Henderson B., Kinane D. Anti-proliferative and cytotoxic activity of surface-associated material from periodontopathogenic bacteria. Arch Oral Biol. 1992 Aug;37(8):637–644. doi: 10.1016/0003-9969(92)90126-s. [DOI] [PubMed] [Google Scholar]
  9. O'Farrell P. H. High resolution two-dimensional electrophoresis of proteins. J Biol Chem. 1975 May 25;250(10):4007–4021. [PMC free article] [PubMed] [Google Scholar]
  10. Page R. C., Ammons W. F. Collagen turnover in the gingiva and other mature connective tissues of the marmoset Saguinus oedipus. Arch Oral Biol. 1974 Aug;19(8):651–658. doi: 10.1016/0003-9969(74)90133-2. [DOI] [PubMed] [Google Scholar]
  11. Saarela M., Asikainen S., Alaluusua S., Pyhälä L., Lai C. H., Jousimies-Somer H. Frequency and stability of mono- or poly-infection by Actinobacillus actinomycetemcomitans serotypes a, b, c, d or e. Oral Microbiol Immunol. 1992 Oct;7(5):277–279. doi: 10.1111/j.1399-302x.1992.tb00588.x. [DOI] [PubMed] [Google Scholar]
  12. Saito A., Hosaka Y., Nakagawa T., Seida K., Yamada S., Takazoe I., Okuda K. Significance of serum antibody against surface antigens of Actinobacillus actinomycetemcomitans in patients with adult periodontitis. Oral Microbiol Immunol. 1993 Jun;8(3):146–153. doi: 10.1111/j.1399-302x.1993.tb00657.x. [DOI] [PubMed] [Google Scholar]
  13. Saito S., Hayakawa M., Takiguchi H., Abiko Y. Suppression of proliferation of a human B-cell leukaemic cell line derived from acute lymphoblastic leukaemia by soluble factor(s) from Campylobacter rectus. Arch Oral Biol. 1993 Jun;38(6):449–455. doi: 10.1016/0003-9969(93)90180-t. [DOI] [PubMed] [Google Scholar]
  14. Shenker B. J., Kushner M. E., Tsai C. C. Inhibition of fibroblast proliferation by Actinobacillus actinomycetemcomitans. Infect Immun. 1982 Dec;38(3):986–992. doi: 10.1128/iai.38.3.986-992.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Stevens R. H., Hammond B. F. The comparative cytotoxicity of periodontal bacteria. J Periodontol. 1988 Nov;59(11):741–749. doi: 10.1902/jop.1988.59.11.741. [DOI] [PubMed] [Google Scholar]
  16. Taichman N. S., Klass J. E., Shenker B. J., Macarak E. J., Boehringer H., Tsai C. C. Suspected periodontopathic organisms alter in vitro proliferation of endothelial cells. J Periodontal Res. 1984 Nov;19(6):583–586. doi: 10.1111/j.1600-0765.1984.tb01319.x. [DOI] [PubMed] [Google Scholar]
  17. Terao N., Saito S., Hayakawa M., Abiko Y. Suppressive effect of soluble factor(s) derived from Prevotella loescheii ATCC 15930 on proliferation of human lymphocytes. Oral Microbiol Immunol. 1992 Aug;7(4):230–234. doi: 10.1111/j.1399-302x.1992.tb00030.x. [DOI] [PubMed] [Google Scholar]
  18. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tsai C. C., McArthur W. P., Baehni P. C., Evian C., Genco R. J., Taichman N. S. Serum neutralizing activity against Actinobacillus actinomycetemcomitans leukotoxin in juvenile periodontitis. J Clin Periodontol. 1981 Aug;8(4):338–348. doi: 10.1111/j.1600-051x.1981.tb02043.x. [DOI] [PubMed] [Google Scholar]
  20. Wilson M., Kamin S., Harvey W. Bone resorbing activity of purified capsular material from Actinobacillus actinomycetemcomitans. J Periodontal Res. 1985 Sep;20(5):484–491. doi: 10.1111/j.1600-0765.1985.tb00831.x. [DOI] [PubMed] [Google Scholar]
  21. Zambon J. J. Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol. 1985 Jan;12(1):1–20. doi: 10.1111/j.1600-051x.1985.tb01348.x. [DOI] [PubMed] [Google Scholar]
  22. Zambon J. J., Umemoto T., De Nardin E., Nakazawa F., Christersson L. A., Genco R. J. Actinobacillus actinomycetemcomitans in the pathogenesis of human periodontal disease. Adv Dent Res. 1988 Nov;2(2):269–274. doi: 10.1177/08959374880020021101. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES